Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
- PMID: 1656869
- PMCID: PMC245234
- DOI: 10.1128/AAC.35.8.1647
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Abstract
Thirteen spontaneous quinolone-resistant gyrB mutants of Escherichia coli KL16, including two that were examined previously, were divided into two types according to their quinolone resistance patterns. Type 1 mutants were resistant to all the quinolones tested, while type 2 mutants were resistant to acidic quinolones and were hypersusceptible to amphoteric quinolones. Nucleotide sequence analysis disclosed that all nine type 1 mutants had a point mutation from aspartic acid to asparagine at amino acid 426 and that all four type 2 mutants had a point mutation from lysine to glutamic acid at amino acid 447.
Similar articles
-
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.Antimicrob Agents Chemother. 1990 Jun;34(6):1271-2. doi: 10.1128/AAC.34.6.1271. Antimicrob Agents Chemother. 1990. PMID: 2168148 Free PMC article.
-
Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region.Antimicrob Agents Chemother. 2001 Aug;45(8):2378-80. doi: 10.1128/AAC.45.8.2378-2380.2001. Antimicrob Agents Chemother. 2001. PMID: 11451702 Free PMC article.
-
Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.FEMS Microbiol Lett. 1993 Jan 15;106(2):187-91. doi: 10.1016/0378-1097(93)90079-h. FEMS Microbiol Lett. 1993. PMID: 8384139
-
Quinolone mode of action--new aspects.Drugs. 1993;45 Suppl 3:8-14. doi: 10.2165/00003495-199300453-00004. Drugs. 1993. PMID: 7689456 Review.
-
Mode of action of the new quinolones: new data.Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):223-31. doi: 10.1007/BF01966994. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1650698 Review.
Cited by
-
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.Sci Rep. 2015 Jul 14;5:11827. doi: 10.1038/srep11827. Sci Rep. 2015. PMID: 26168713 Free PMC article. Clinical Trial.
-
Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms.Antimicrob Agents Chemother. 1999 Dec;43(12):2998-3000. doi: 10.1128/AAC.43.12.2998. Antimicrob Agents Chemother. 1999. PMID: 10582896 Free PMC article.
-
ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae.J Bacteriol. 2003 Oct;185(20):6137-46. doi: 10.1128/JB.185.20.6137-6146.2003. J Bacteriol. 2003. PMID: 14526026 Free PMC article.
-
Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.Antimicrob Agents Chemother. 2005 Jan;49(1):118-25. doi: 10.1128/AAC.49.1.118-125.2005. Antimicrob Agents Chemother. 2005. PMID: 15616284 Free PMC article.
-
Molecular typing and profiling of topoisomerase mutations causing resistance to ciprofloxacin and levofloxacin in Elizabethkingia species.PeerJ. 2018 Sep 12;6:e5608. doi: 10.7717/peerj.5608. eCollection 2018. PeerJ. 2018. PMID: 30225179 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases